Profound Medical Corp. PRN.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -35.26% | 13.72% | -2.49% | 49.18% | -46.35% |
| Total Depreciation and Amortization | 35.00% | -8.26% | -25.85% | 4.26% | -13.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.96% | -19.90% | -17.40% | 15.44% | 40.47% |
| Change in Net Operating Assets | -4.65% | -2,321.95% | 103.56% | -1,043.17% | -70.72% |
| Cash from Operations | -32.10% | -30.72% | 31.70% | 30.05% | -65.93% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | 100.00% |
| Foreign Exchange rate Adjustments | 18.82% | -405.05% | 136.69% | -130.13% | 2,565.96% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.54% | -127.02% | 436.55% | 7.73% | -32.54% |